CS Medica A/S Logo

CS Medica A/S Claim profile

ISIN: DK0061668225 | Ticker: CSMED | LEI: 549300SC8KWO7JFWLN17

About CS Medica A/S

Company Description

CS MEDICA is a Danish-based MedTech combining science and nature with the purpose of creating products for a better every day. By using modern technology to research and utilize different compounds found in the cannabis plant, we create world-changing products that offer efficient and safe treatment of autoimmune and stress-related disorders.

Founded in 2016, we discovered an untapped potential for the use of cannabinoids in the healthcare treatment sector and in 2021, after extensive research and development, we launched medical device products across international markets, supplying people worldwide with an efficient, safe OTC alternative. As we continue to research, develop, manufacture, commercialize and build brands, we aim to revolutionize the medical and cannabis industries, with science and nature in our hearts.

Year founded

2011

Served area

Worldwide

Headquarters

Fruebjergvej 3, 2100 Copenhagen – Denmark

Filings & Publications

2022

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding

12,320,000

IPO

Sept. 14, 2021

Stock exchange(s)

Nasdaq Copenhagen

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.